Activation of Endothelial Toll-Like Receptor 3 Impairs Endothelial Function
暂无分享,去创建一个
C. Coch | G. Hartmann | S. Zimmer | G. Nickenig | W. Barchet | S. Wassmann | M. Steinmetz | Evelyn Hartmann | T. Asdonk | Inga Motz
[1] S. Akira,et al. Activation of MDA5 Requires Higher-Order RNA Structures Generated during Virus Infection , 2009, Journal of Virology.
[2] Osamu Takeuchi,et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. , 2009, Immunity.
[3] J. Ambati,et al. Small interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growth , 2009, Proceedings of the National Academy of Sciences.
[4] Daniel R. Caffrey,et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1 activating inflammasome with ASC , 2009, Nature.
[5] K. Preissner,et al. A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. , 2009, Blood.
[6] C. Stefanadis,et al. Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases. , 2008, Atherosclerosis.
[7] U. Laufs,et al. Heart Rate Reduction by Ivabradine Reduces Oxidative Stress, Improves Endothelial Function, and Prevents Atherosclerosis in Apolipoprotein E–Deficient Mice , 2008, Circulation.
[8] D. Davies,et al. Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.
[9] Justine R. Smith,et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 , 2008, Nature.
[10] G. Ertl,et al. Mechanisms of Disease: Toll-like receptors in cardiovascular disease , 2007, Nature Clinical Practice Cardiovascular Medicine.
[11] K. Honda,et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.
[12] Myeong Sup Lee,et al. Signaling pathways downstream of pattern-recognition receptors and their cross talk. , 2007, Annual review of biochemistry.
[13] Myeong Sup Lee,et al. Pattern-recognition receptor signaling initiated from extracellular, membrane, and cytoplasmic space. , 2007, Molecules and cells.
[14] C. Liang,et al. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro , 2007, Nature Protocols.
[15] R. Weissleder,et al. Oligomerization of CXCL10 Is Necessary for Endothelial Cell Presentation and In Vivo Activity1 , 2006, The Journal of Immunology.
[16] Gunther Hartmann,et al. 5'-Triphosphate RNA Is the Ligand for RIG-I , 2006, Science.
[17] S. Ryter,et al. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts , 2006, The Journal of experimental medicine.
[18] Richard A Flavell,et al. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[19] K. Moore,et al. Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells , 2006, Circulation.
[20] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[21] K. Maruyama,et al. Endothelial Progenitor Thrombospondin-1 Mediates Diabetes-Induced Delay in Reendothelialization Following Arterial Injury , 2006, Circulation research.
[22] G. Nickenig,et al. Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005, The New England journal of medicine.
[23] G. Nickenig,et al. In vitro differentiation characteristics of cultured human mononuclear cells-implications for endothelial progenitor cell biology. , 2005, Biochemical and biophysical research communications.
[24] G. Pasterkamp,et al. Toll-like receptor 2 stimulation induces intimal hyperplasia and atherosclerotic lesion development. , 2005, Cardiovascular research.
[25] S. Ye,et al. Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction , 2005, Pharmacogenetics and genomics.
[26] S. Akira,et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[28] M. Stumpf,et al. Interleukin-6 Induces Oxidative Stress and Endothelial Dysfunction by Overexpression of the Angiotensin II Type 1 Receptor , 2004, Circulation research.
[29] A. Bennaceur-Griscelli,et al. From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2002 .
[30] A. Quyyumi,et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. , 2003, The New England journal of medicine.
[31] M. Endres,et al. Bone Marrow–Derived Progenitor Cells Modulate Vascular Reendothelialization and Neointimal Formation: Effect of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[32] U. Laufs,et al. Raloxifene Improves Endothelial Dysfunction in Hypertension by Reduced Oxidative Stress and Enhanced Nitric Oxide Production , 2002, Circulation.
[33] S. Akira,et al. A Toll-like receptor recognizes bacterial DNA , 2000, Nature.
[34] K. Williams,et al. Atherosclerosis--an inflammatory disease. , 1999, The New England journal of medicine.
[35] P. Tipping,et al. Interleukin-8 production by macrophages from atheromatous plaques. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[36] Andrew D. Luster,et al. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.
[37] P. Chambon,et al. Estradiol alters nitric oxide production in the mouse aorta through the alpha-, but not beta-, estrogen receptor. , 2002, Circulation research.